The Synthesis Company GTM brain

The Synthesis Company offers Eva, an AI-assisted evidence synthesis system for pharma, CRO and academic research teams.

category

AI evidence synthesis

market profile

  • text: Systematic reviews demand screening and extraction across large scientific literature collections, with verification by subject experts.
  • text: Evidence synthesis tools compete across search, screening and extraction; published research notes accuracy remains a consideration.

personas

  • title: Systematic review lead
    pains:
    • Abstract screening and full-text extraction consume scarce expert time
    • New publications make completed reviews stale
  • title: Pharma evidence generation or HEOR director
    pains:
    • Needs timely, defensible evidence for therapy decisions
    • Must trace extracted outcomes and assess AI errors before relying on findings
  • title: CRO research operations leader
    pains:
    • Client review projects compete for limited reviewer capacity
    • Standardized documentation and human adjudication are needed across projects

icp

  • text: Pharmaceutical evidence teams and CROs conducting systematic or living reviews, especially where literature is too large for a quick manual update.
  • text: Academic clinical research groups with domain experts who can adjudicate automated screening and extraction; company size is not specified.

message pillars

  • text: Agents do review work while humans retain adjudication.
  • text: Keep the review current as evidence changes.
  • text: Make findings traceable and reviewer guided.

objections

  • objection: Can AI screening and extraction be trusted for our research question?
    response: Review the published validation methods and test against an expert-labeled sample in the target domain before relying on results.
  • objection: Will automation remove expert control?
    response: Eva's described workflow leaves adjudication to reviewers and connects extraction to citations.

competitors

  • name: Elicit
    website: https://elicit.com/pricing?redirected=true
    why: Offers AI-assisted systematic review screening and extraction.
  • name: Covidence
    why: Provides systematic review screening and workflow software.
  • name: DistillerSR
    why: Supports systematic evidence reviews and screening workflows.

influencers

  • name: Cyrus Nouroozi
    url: https://www.ycombinator.com/companies/the-synthesis-company
    why: Founder and CEO focused on evidence synthesis.

keywords

  • AI systematic literature review
  • living evidence synthesis
  • pharma systematic review automation
  • AI abstract screening
  • systematic review data extraction
  • HEOR evidence synthesis

voice

  • scientific
  • confident
  • human-centered

signals

  • text: A pharma or CRO team is commissioning a large review or recurring evidence updates.
  • text: Researchers face a screening backlog and need traceable, expert-reviewed extraction.

pricing

model: unknown

motion

sales_led

channels

  • Website
  • LinkedIn
  • research conferences

confidence

medium

Founders

  • name: Cyrus Nouroozi
    title: Founder/CEO
    role: CEO
    bio: Previous cofounder @ The Synthesis Company of California, core contributor @ Stanford NLP's DSPy, AI Researcher @ Nous Research, cofounder @ Wombo.ai. He's been called bottled lightning, a 95th percentile AI researcher (after 4 months of self-studying), and a beautiful soul. He enjoys the little moments in a day with coffee, ecstatic dance, and tai chi.
  • name: Amir Mehr
    title: Founder/CTO
    role: CTO
    bio: With a Master’s in Computer Science from the University of Calgary and as a key contributor to StanfordNLP's DSPy project, Amir has deep expertise in AI and software engineering. He played a crucial role in engineering at HubMeta and OVOU. His early success running a profitable web hosting business in high school showcases his technical acumen and entrepreneurial drive.

Back to YC companies